Common adverse effects include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting up to 40% of users) Reduced appetite and weight loss Injection site reactions redness, itching, or discomfort Hypoglycaemia particularly when used alongside insulin or sulfonylureas More serious but rare adverse effects include pancreatitis (inflammation of the pancreas) and gallbladder disease
Lyophilized BPC-157 should be stored at 28C and protected from light
Enzyme A and Enzyme B, respectively, are A
Stacking risk: Combining Dihexa with other nootropics, stimulants, or growth factor enhancers could amplify risks of overstimulation or tumorigenesis
It significantly increases IGF-1 levels
About This Event Tuesday, April 14 | Free Admission & Parking 5-6 P.M